FindTrial
Sign In

The usefulness of serum AsAGP levels for diagnosis of liver cirrhosios.

A single institutional, clinical trial to determine the diagnostic capacity of cirrhosis by measuring serum AsAGP levels.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0003648
Enrollment
84
Registered
2019-03-20
Start date
2018-06-11
Completion date
Unknown
Last updated
2019-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Hanyang University Seoul Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with chronic liver disease - Patients with chronic hepatitis and nonalcoholic fatty liver disease. - Include 25 patients with non-alcoholic fatty liver disease among patients with chronic liver disease. Patient with cirrhosis. - Patients with cirrhosis. - Include 25 patients with early cirrhosis (Child Pugh Class A) among patients with cirrhosis.

Exclusion criteria

Exclusion criteria: Patient with an artificial pacemaker Patient who is difficult to perform MRI by insertion of metallic material. Patient with malignant tumor except for hepatocellular carcinoma Pregnant woman. Patient without written consent.

Design outcomes

Primary

MeasureTime frame
Assessment of AUC of cirrhosis diagnosed via MRE (> 5.0 kPa)—

Secondary

MeasureTime frame
Sensitivity to the presence of cirrhosis diagnosed via MRE—

Countries

Korea, Republic of

Contacts

Public ContactDae Won Jun

Hanyang University

gongori1004@gmail.com+82-2-2290-9164

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026